ErepoXen: Phase I/IIa started

Xenetic said its partner the Serum Institute began an open-label, Indian Phase I/IIa trial to evaluate IV ErepoXen in 40 chronic renal failure patients on dialysis. Xenetic and the Serum Institute are...